Sol-Gel Technologies Debt/Equity Ratio 2016-2024 | SLGL

Sol-Gel Technologies debt/equity ratio from 2016 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.

Sol-Gel Technologies Debt/Equity Ratio 2016-2024 | SLGL

Sol-Gel Technologies debt/equity ratio from 2016 to 2024. Debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19B
Dr Reddy's Laboratories (RDY)$12B
BridgeBio Pharma (BBIO)$4.3B
Bausch Health Cos (BHC)$3B
Amphastar Pharmaceuticals (AMPH)$2.1B
Supernus Pharmaceuticals (SUPN)$2B
Taysha Gene Therapies (TSHA)$434M
Personalis (PSNL)$261M
Assembly Biosciences (ASMB)$98M
Evoke Pharma (EVOK)$7M
Teligent (TLGT)$0M